ライフサイエンスコーパス: pyoderma

1 damycin is increasingly used to treat canine pyoderma.

2 0.06% for malignant skin melanoma, 0.05% for pyoderma, 0.04% for cellulitis, 0.03% for keratinocyte c

3 tion vaccine were strongly protected against pyoderma and bacteremia, as evidenced by a 100-1000-fold

4 st common microorganism isolated from canine pyoderma and postoperative wound infections.

5 we show that the vaccine can protect against pyoderma and subsequent bacteremia caused by multiple GA

6 primarily limited to the treatment of canine pyoderma caused by methicillin-resistant Staphylococcus

7 Pyoderma Gangrenosum (PG) is a cutaneous condition, its

8 Pyoderma gangrenosum (PG) is an important disease with s

9 Peristomal pyoderma gangrenosum (PPG), an unusual variant of pyoder

10 e in which cutaneous manifestations, such as pyoderma gangrenosum and acne fulminans, predominated.

11 arthritis and less frequently accompanied by pyoderma gangrenosum and acne.

12 mic inflammatory disease; pyogenic arthritis pyoderma gangrenosum and acne; Muckle-Wells syndrome; fa

13 from patients with Sweet's syndrome (SW) and pyoderma gangrenosum and found numerous novel splice var

14 functions of PSTPIP1 in the pathogenesis of pyoderma gangrenosum and suggest that the cytoskeleton i

15 report a case of CB, initially diagnosed as pyoderma gangrenosum and treated with steroids, leading

16 of the 157 consecutive patients treated for pyoderma gangrenosum at our institution (10 percent).

17 illation-associated disease and suggest that pyoderma gangrenosum can be classified as a dynamical di

18 gnosis of exclusion, and the misdiagnosis of pyoderma gangrenosum can result in substantial complicat

19 Among other entities, CB may be mistaken for pyoderma gangrenosum due to overlap of findings on histo

20 95 patients studied, 64 had been treated for pyoderma gangrenosum for a median of 10 months (range, 3

21 57 consecutive patients treated for presumed pyoderma gangrenosum from 1984 through 1992.

22 Here we report the first case of pyoderma gangrenosum in a patient with refractory celiac

23 required in all patients suspected of having pyoderma gangrenosum in order to rule out alternative di

24 Pyoderma gangrenosum is a diagnosis of exclusion, and th

25 Pyoderma gangrenosum is an inflammatory neutrophilic der

26 Pyoderma gangrenosum is associated with a concomitant sy

27 The misdiagnosis of pyoderma gangrenosum is not uncommon and exposes patient

28 ssibility that refractory celiac disease and pyoderma gangrenosum may be immunologically different.

29 s detected in all other patients with either pyoderma gangrenosum or SW, it was always associated wit

30 A pyoderma gangrenosum patient exhibiting aberrant leukocy

31 Good resolution of pyoderma gangrenosum was achieved in 3 patients with tum

32 e charts of 240 patients with a diagnosis of pyoderma gangrenosum who were evaluated at our instituti

33 Pyogenic sterile arthritis, pyoderma gangrenosum, and acne (PAPA) syndrome (OMIM 604

34 dominant disease called pyogenic arthritis, pyoderma gangrenosum, and acne (PAPA) syndrome.

35 to cause the syndrome of pyogenic arthritis, pyoderma gangrenosum, and acne (PAPA), a dominantly inhe

36 Pyogenic Arthritis, Pyoderma Gangrenosum, and Acne Syndrome (PAPA syndrome)

37 generation (MRST); and a pyogenic arthritis, pyoderma gangrenosum, and acne syndrome (PAPA).

38 ver syndrome and pyogenic sterile arthritis, pyoderma gangrenosum, and acne syndrome.

39 PAPA syndrome (pyogenic sterile arthritis, pyoderma gangrenosum, and acne, OMIM #604416) and famili

40 e PAPA syndrome: pyogenic sterile arthritis, pyoderma gangrenosum, and acne.

41 Pyoderma gangrenosum, cystic acne, and aseptic arthritis

42 rma gangrenosum (PPG), an unusual variant of pyoderma gangrenosum, has been reported almost exclusive

43 Of the ulcers in the 64 patients treated for pyoderma gangrenosum, it was clear that those in 23 pati

44 nt) did not respond to treatment directed at pyoderma gangrenosum, those in 8 (12 percent) were exace

45 nt, rarely occurring, extra-hepatic onset of pyoderma gangrenosum, with the AIH in remission, strengt

46 port mapping of a disease locus for familial pyoderma gangrenosum-acne-arthritis to the long arm of c

47 tion in a patient presenting with aggressive pyoderma gangrenosum.

48 samples confirmed the clinical suspicion of pyoderma gangrenosum.

49 stations included pathergy, cystic acne, and pyoderma gangrenosum.

50 ations are discussed regarding psoriasis and pyoderma gangrenosum.

51 d skin ulcers with a clinical resemblance to pyoderma gangrenosum.

52 abscesses and pretibial lesions diagnosed as pyoderma gangrenosum.

53 ic vasculitides such as Sweet's syndrome and pyoderma gangrenosum.

54 , the frequent association of SECcanine with pyoderma in dogs supports the notion that the toxins are